TriangleFOR PATIENTS · SOURCE READING
Treatment of Metastatic Gastrointestinal Neuroendocrine Tumors
Source: Gastrointestinal Neuroendocrine Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 20, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, see the Treatment Option Overview section.
Source links and citations
Distant metastases
Treatment of distant metastases of gastrointestinal (GI) neuroendocrine tumors is usually palliative therapy to relieve symptoms and improve quality of life. Treatment may include:
Source links and citations
Surgery (resection) to remove as much of the tumor as possible.
Hormone therapy.
Source links and citations
Radiopharmaceutical therapy.
Source links and citations
External radiation therapy for cancer that has spread to the bone, brain, or spinal cord.
Source links and citations
A clinical trial of a new treatment.
Source links and citations
Liver metastases
Treatment of cancer that has spread to the liver may include:
Source links and citations
Hepatic artery embolization.
Source links and citations
Cryosurgery.
Source links and citations
Radiofrequency ablation.
Source links and citations
Liver transplant.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice